Home › Funds › Englebert Financial Advisers, LLC › VKTX

Englebert Financial Advisers, LLC position in VKTX

VIKING THERAPEUTICS INC · Health Care

Englebert Financial Advisers, LLC reported holding 11,228 shares of VKTX (VIKING THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$366K, representing 0.38% of its reported portfolio and ranking #43 among its reported holdings. Englebert Financial Advisers, LLC has disclosed VKTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)11.23K sh
Reported value held$366.05K
Portfolio Weight0.38%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Englebert Financial Advisers, LLC's VKTX position evolved

Englebert Financial Advisers, LLC first disclosed a stake in VKTX in Q4 2025 at 11,761 shares (US$414K). The position peaked in Q2 2026 at 11,699 shares, worth US$456K. Across 4 filings, Englebert Financial Advisers, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 11,228 shares valued at US$366K — a reduction of -471 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 11.76K $413.75K New
Q1 2026 11.77K $383.09K Hold
Q2 2026 11.70K $456.38K Reduce
Q3 2026 11.23K $366.05K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has Englebert Financial Advisers, LLC held VKTX?

Englebert Financial Advisers, LLC has disclosed VKTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Englebert Financial Advisers, LLC's current position in VKTX?

As of Q3 2026, Englebert Financial Advisers, LLC holds 11.23K shares of VKTX (VIKING THERAPEUTICS INC), valued at $366.05K, representing 0.38% of its reported portfolio and ranking #43.

Has Englebert Financial Advisers, LLC been buying or selling VKTX?

In the latest 13F filing (Q3 2026), Englebert Financial Advisers, LLC reduced its position in VKTX. The position peaked in Q2 2026 at 11.70K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.